Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2000
11/01/2000CN1271605A Process for preparing medicine to cure viral hepatitis
11/01/2000CN1271594A Instant particles 'Yigansan'
11/01/2000CN1271585A Multifunctional nutritive isomaltoligose syrup
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057935C Chinese medicinal power preparation for treating hepatocirrhosis
11/01/2000CN1057934C Instant particle for benefiting liver and preparation method thereof
11/01/2000CN1057926C Medicinal composition for curing gastrointestinal disease
11/01/2000CN1057922C Medicine for treatment of constipation
11/01/2000CN1057912C Chinese medicine for treatment of cholecystitis
10/2000
10/31/2000US6140512 Process for the production of lipoic acid
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140337 Methods for the treatment of mental disorders
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140308 Colon or ileum-specific glucocorticosteroid derivatives
10/31/2000US6139863 Suppositories
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/31/2000CA2142879C Method of treating cell damage or depletion
10/31/2000CA2116535C A method for treatment of patients with chronic liver disease
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000WO2000063215A2 Indazole derivatives, preparation and therapeutic application thereof
10/26/2000WO2000063211A1 Haloalkoxy imidazonaphthyridines
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000062806A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000WO2000062797A1 Remedies for autonomic neuropathy
10/26/2000WO2000062796A1 Agents for ameliorating pancreatic function disorder
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062780A1 Use of glucosylceramide synthesis inhibitors in therapy
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062773A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062764A1 Gum pad for delivery of medication to mucosal tissues
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000035919A3 Quinoline derivatives
10/26/2000WO2000032188A3 Use of amtolmetin guacyl as an antiinflammatory drug
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000007577A3 Phosphatidylcholine as a medicament for the protection of mucosa
10/26/2000DE19918434A1 Storage-stable solid proton pump inhibitor formulation useful e.g. for treating duodenal ulcers, comprises amorphous active agent embedded in auxiliary matrix
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2370231A1 Haloalkoxy imidazonaphthyridines
10/26/2000CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046398A1 Preparation of a medicament containing polyphenol compounds of catechic or flavonylic type from plants, especially for the treatment of gingivitis
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045832A2 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045696A1 Oral oil sorbing composition
10/25/2000EP1045695A1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000EP1045687A1 Preparation for dental treatment
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271292A Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270835A Gastrosis treating medicine and its preparation
10/25/2000CN1270828A Medicine powder for treating toothache and strengthening tooth
10/25/2000CN1270825A Chinese medicine for treading hepatitis A and B and its recipe
10/25/2000CN1270824A Tonic wine capable of promoting blood circulation
10/25/2000CN1270820A Tonic compound deer fetus ointment and its preparation
10/25/2000CN1270816A Youth and longevity pellet and its preparation
10/25/2000CN1270815A Medicated wine capable of treating several disease
10/25/2000CN1270809A Application of tanhin polyphenolic B magnesium in preparing medicine for treating chronic hepatosis
10/25/2000CN1057701C Health-care inlalant of loguat leaf and preparing method
1 ... 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 ... 1258